Gene: ZFHX4
Official Full Name: zinc finger homeobox 4provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12407 | ZFHX4 Knockout cell line (HCT 116) | Human | ZFHX4 | 1:2~1:4 | Negative | Online Inquiry |
KO12408 | ZFHX4 Knockout cell line (HEK293) | Human | ZFHX4 | 1:3~1:6 | Negative | Online Inquiry |
KO12409 | ZFHX4 Knockout cell line (A549) | Human | ZFHX4 | 1:3~1:4 | Negative | Online Inquiry |
ZFHX4 Gene Knockout Cell Lines are a sophisticated tool developed for advanced genetic research, specifically designed to facilitate the study of the ZFHX4 gene, known for its critical role in regulating cellular processes such as differentiation, proliferation, and development. Utilizing CRISPR-Cas9 technology, these cell lines enable the precise and efficient deletion of the ZFHX4 gene, allowing researchers to investigate the resultant phenotypic changes and elucidate the gene's functions within various biological contexts.
The primary function of ZFHX4 Gene Knockout Cell Lines lies in their ability to model genetic deficiencies, providing insights into the gene's involvement in disease mechanisms and therapeutic responses. By creating a controlled environment where ZFHX4 is absent, researchers can observe downstream effects on cell signaling pathways, gene expression profiles, and overall cellular behavior. This targeted approach not only streamlines the investigation of gene function but also enhances the reproducibility and reliability of experimental results.
The scientific importance of these cell lines extends into multiple domains, including cancer research, developmental biology, and regenerative medicine. In clinical settings, understanding ZFHX4’s role may reveal new therapeutic targets for conditions where its dysregulation is implicated, fostering the development of innovative treatment strategies.
What sets our ZFHX4 Gene Knockout Cell Lines apart from conventional gene-silencing methods is their specificity and efficiency. Unlike RNA interference techniques that may result in off-target effects, our knockout cell lines provide definitive evidence for loss-of-function phenotypes. Additionally, the ease of use and adaptability for high-throughput screening make these lines indispensable for researchers aiming to accelerate their studies while minimizing labor-intensive protocols.
Researchers and clinicians alike will find exceptional value in the insights gained from the ZFHX4 Gene Knockout Cell Lines, empowering investigations that can lead to groundbreaking discoveries in genetics and molecular biology. By using our state-of-the-art cell lines, you are leveraging the expertise of a company committed to advancing scientific research through innovative and high-quality biological products, ensuring you remain at the forefront of your field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.